
COVID-19 e hipertension arterial: ¿existe evidencia para suspender antagonista sistema renina angiotensina?
Author(s) -
Ignacio Villanueva Bendek,
Roberto Ramírez Marmolejo,
Juan Diego Montejo,
Joaquín Rodelo Ceballos,
Luis Puello González,
María Vélez Verbel,
Laura Gómez Franco
Publication year - 2020
Publication title -
revista colombiana de nefrología
Language(s) - Portuguese
Resource type - Journals
eISSN - 2500-5006
pISSN - 2389-7708
DOI - 10.22265/acnef.7.supl.2.405
Subject(s) - medicine , renin–angiotensin system , covid-19 , angiotensin converting enzyme 2 , disease , angiotensin receptor blockers , pathophysiology , receptor , angiotensin ii , diabetes mellitus , coronavirus , bioinformatics , pharmacology , endocrinology , virology , blood pressure , biology , infectious disease (medical specialty) , outbreak